Difference between revisions of "Topiramate"

From Psychiatrienet
Jump to: navigation, search
(Created page with '{{Drug | name = topiramate | group = anticonvulsant | type = Moodstabilizer | medscape = 14496 | pubchem = 5284627 | drugscom = topiramate | ftk = topiramaat | ATC = N03AX11 | ad...')
 
Line 8: Line 8:
 
| ftk = topiramaat
 
| ftk = topiramaat
 
| ATC = N03AX11
 
| ATC = N03AX11
| administration = Oral
+
| metabolization = Topiramate induces CYP3A4 and is an inhibitor of CYP2C19.
| ctox =
 
| halflife = 21
 
| halflife_ref = <ref name="ftk">{{FTK|topiramaat}}</ref>
 
| cth =
 
| metabolites = 1
 
| metabolites_ref = <ref name="informatorium">{{KNMP|topiramaat}} </ref>
 
| bioavailability = 50
 
| bioavailability_ref = <ref name="ftk">{{FTK|topiramaat}}</ref>
 
 
<includeonly>
 
<includeonly>
 
| isswitch = 1
 
| isswitch = 1
 
</includeonly>
 
</includeonly>
 
}}
 
}}

Revision as of 14:33, 4 March 2010

topiramate
Type Moodstabilizer
Group anticonvulsant
links
ATC-code N03AX11
PubChem 5284627
PubMed topiramate
Drugs.com topiramate
Kompas (Dutch) topiramate
Wikipedia topiramate

topiramate is a Moodstabilizer in the group anticonvulsant.


Metabolization

Topiramate induces CYP3A4 and is an inhibitor of CYP2C19.